244 related articles for article (PubMed ID: 32366782)
21. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
22. Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype.
Terzi YK; Sirin B; Serdaroglu E; Anlar B; Aysun S; Hosgor G; Arslan EA; Ayter S
Childs Nerv Syst; 2011 Dec; 27(12):2113-6. PubMed ID: 21732117
[TBL] [Abstract][Full Text] [Related]
23. Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
Castellanos E; Rosas I; Negro A; Gel B; Alibés A; Baena N; Pineda M; Pi G; Pintos G; Salvador H; Lázaro C; Blanco I; Vilageliu L; Brems H; Grinberg D; Legius E; Serra E
Clin Genet; 2020 Feb; 97(2):264-275. PubMed ID: 31573083
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Novel
Xu G; Li M; Niu Y; Huang X; Li Y; Tang G; Long S; Zhao H; Jiang H
Biomed Res Int; 2019; 2019():2721357. PubMed ID: 31886188
[TBL] [Abstract][Full Text] [Related]
25. A case of non-Hodgkin's lymphoma in a patient with neurofibromatosis type 1.
Kim SJ; Seo JH; Lee SW; Han E; Lee ES; Cha SH; Seo BK
Korean J Intern Med; 2003 Sep; 18(3):202-5. PubMed ID: 14619393
[TBL] [Abstract][Full Text] [Related]
26. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
27. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
28. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
[TBL] [Abstract][Full Text] [Related]
29. [Unusual clinical manifestations of type 1 neurofibromatosis].
Komlósi K; Polgár N; Hadzsiev K; Ottóffy G; Illés T; Dóczi T; Melegh B
Orv Hetil; 2011 Dec; 152(49):1965-70. PubMed ID: 22106164
[TBL] [Abstract][Full Text] [Related]
30. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
32. Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1.
Guo YX; Wang HX; Wang SS; Croitoru D; Piguet V; Gao XH; Xu XG
JAMA Dermatol; 2024 Mar; 160(3):366-368. PubMed ID: 38198164
[TBL] [Abstract][Full Text] [Related]
33. Malignant Peripheral Nerve Sheath Tumor in an Army Reservist With Neurofibromatosis Type 1.
Kou CJ; Rendo M; Broadwater DR; Beeler B
Mil Med; 2021 May; 186(5-6):e626-e631. PubMed ID: 33180928
[TBL] [Abstract][Full Text] [Related]
34. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.
Pasmant E; Gilbert-Dussardier B; Petit A; de Laval B; Luscan A; Gruber A; Lapillonne H; Deswarte C; Goussard P; Laurendeau I; Uzan B; Pflumio F; Brizard F; Vabres P; Naguibvena I; Fasola S; Millot F; Porteu F; Vidaud D; Landman-Parker J; Ballerini P
Oncogene; 2015 Jan; 34(5):631-8. PubMed ID: 24469042
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders.
Giugliano T; Santoro C; Torella A; Del Vecchio Blanco F; Grandone A; Onore ME; Melone MAB; Straccia G; Melis D; Piccolo V; Limongelli G; Buono S; Perrotta S; Nigro V; Piluso G
Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31370276
[TBL] [Abstract][Full Text] [Related]
36. Epilepsy in Legius syndrome: Coincidence or causation?
Medina Lemus A; Boelman C; Myers KA
Am J Med Genet A; 2024 Jun; 194(6):e63547. PubMed ID: 38268057
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
[TBL] [Abstract][Full Text] [Related]
38. [Neurofibromatosis 1].
Yoshida Y
Brain Nerve; 2019 Apr; 71(4):368-372. PubMed ID: 30988223
[TBL] [Abstract][Full Text] [Related]
39. Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).
Zhang J; Li M; Yao Z
Mol Med Rep; 2016 Nov; 14(5):4023-4029. PubMed ID: 27666661
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 1 with overlap Turner syndrome and Klinefelter syndrome.
Hatipoglu N; Kurtoglu S; Kendirci M; Keskin M; Per H
J Trop Pediatr; 2010 Feb; 56(1):69-72. PubMed ID: 19578129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
